Clinical Trials Browser

Phase 2/3 × Breast Neoplasms × Carnitine × Clear all

NCT00247975 2022-08-16

Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

Phase 2/3 Terminated

Breast Neoplasms, Heart Failure